Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

March 2013 - FRMC

Department
03/19/2013
The FDA approved ABRAXANE® for Injectable Suspension as first-line treatment for patients with locally advanced or metastatic non–small-cell lung cancer.
The FDA approved ABRAXANE® for Injectable Suspension as first-line treatment for patients with locally advanced or metastatic non–small-cell lung cancer.
The FDA approved ABRAXANE® for...
03/19/2013
First Report Managed Care
03/19/2013

Tim Casey

Tim Casey
Las Vegas—Although only between 1% and 5% of people use specialty drugs, those products account for 20% of total drug spending, a percentage that is expected to increase to 40% in the coming years, according to HungChing Chan, vice president...
Las Vegas—Although only between 1% and 5% of people use specialty drugs, those products account for 20% of total drug spending, a percentage that is expected to increase to 40% in the coming years, according to HungChing Chan, vice president...
Las Vegas—Although only between...
03/19/2013
First Report Managed Care
03/19/2013

Tim Casey

Tim Casey
Las Vegas—In 2009, pharmacy spending accounted for 16% of Whirlpool Corporation’s healthcare spending. Of the 22,000 employees, an increasing number had chronic conditions, including diabetes, coronary artery disease, and asthma. Stacy White,...
Las Vegas—In 2009, pharmacy spending accounted for 16% of Whirlpool Corporation’s healthcare spending. Of the 22,000 employees, an increasing number had chronic conditions, including diabetes, coronary artery disease, and asthma. Stacy White,...
Las Vegas—In 2009, pharmacy...
03/19/2013
First Report Managed Care
03/19/2013

Tim Casey

Tim Casey
Las Vegas—Providers are usually careful when prescribing opioids and pain medications. The drugs are associated with the potential for misuse and abuse, although there is no single factor to predict whether someone will experience from these...
Las Vegas—Providers are usually careful when prescribing opioids and pain medications. The drugs are associated with the potential for misuse and abuse, although there is no single factor to predict whether someone will experience from these...
Las Vegas—Providers are usually...
03/19/2013
First Report Managed Care
03/19/2013

Tim Casey

Tim Casey
Las Vegas—As Citi Investment Research’s director of healthcare technology and distribution, George Hill spends most of his days researching and speaking with numerous people in the healthcare industry. Through the conversations and analyses,...
Las Vegas—As Citi Investment Research’s director of healthcare technology and distribution, George Hill spends most of his days researching and speaking with numerous people in the healthcare industry. Through the conversations and analyses,...
Las Vegas—As Citi Investment...
03/19/2013
First Report Managed Care
03/19/2013

Jill Sederstrom

Jill Sederstrom
The use of electronic health record (EHR) systems in office-based physician practices continues to rise, but the prevalence of these systems varies significantly by state. These are just a few of the conclusions drawn from a recent data brief...
The use of electronic health record (EHR) systems in office-based physician practices continues to rise, but the prevalence of these systems varies significantly by state. These are just a few of the conclusions drawn from a recent data brief...
The use of electronic health...
03/19/2013
First Report Managed Care
03/19/2013

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
A study in male Wistar rats found that the microparticulate dosage form of lansoprazole provided effective drug concentration for a longer duration than the conventional extended-release dosage form. Furthermore, the dosage form showed...
A study in male Wistar rats found that the microparticulate dosage form of lansoprazole provided effective drug concentration for a longer duration than the conventional extended-release dosage form. Furthermore, the dosage form showed...
A study in male Wistar rats...
03/19/2013
First Report Managed Care

Department

Conference Insider
03/19/2013

Tim Casey

Tim Casey
Las Vegas—With several blockbuster drugs losing patent protection in recent years, companies have increased their use of copay or voucher programs, in which drug or device manufacturers provide financial assistance to patients to continue...
Las Vegas—With several blockbuster drugs losing patent protection in recent years, companies have increased their use of copay or voucher programs, in which drug or device manufacturers provide financial assistance to patients to continue...
Las Vegas—With several...
03/19/2013
First Report Managed Care
News Connection
03/19/2013

Tori Socha

Tori Socha
Patients discharged from the hospital are at risk in the immediate postdischarge (PD) period. In the 6 months following an index hospitalization, nearly 1 in 7 surgical patients who were accounted for in the Medicare fee-for-service program...
Patients discharged from the hospital are at risk in the immediate postdischarge (PD) period. In the 6 months following an index hospitalization, nearly 1 in 7 surgical patients who were accounted for in the Medicare fee-for-service program...
Patients discharged from the...
03/19/2013
First Report Managed Care
Conference Insider
03/19/2013

Tori Socha

Tori Socha
Accountable care organizations (ACOs) are increasingly being created as payment models designed to improve care and slow the growth of healthcare costs. The Centers for Medicare & Medicaid Services (CMS) has created 3 ACOs that differ in...
Accountable care organizations (ACOs) are increasingly being created as payment models designed to improve care and slow the growth of healthcare costs. The Centers for Medicare & Medicaid Services (CMS) has created 3 ACOs that differ in...
Accountable care organizations...
03/19/2013
First Report Managed Care

Advertisement

Advertisement

Advertisement